MENU

Stephen C. Rubin, MD, Named Chief of Gynecologic Oncology at Fox Chase Cancer Center

March 6, 2014

PHILADELPHIA, PA (March 6, 2014)—Stephen C. Rubin, MD, has joined the Department of Surgical Oncology at Fox Chase Cancer Center as Chief of Gynecologic Oncology, where he will specialize in the treatment of patients with gynecologic cancers—including ovarian, uterine, cervical, and endometrial. Dr. Rubin has also been named Co-Clinical Leader of the Gynecological Service Line and Professor in the clinical investigator track of the Department of Surgical Oncology. In addition, he will hold the Paul Grotzinger and Wilbur Raab Chair in Surgical Oncology.

“Fox Chase has long been a national leader in research and treatment of women’s cancers, with special expertise in gynecological cancers,” says Richard I. Fisher, MD, President and CEO of Fox Chase. “The arrival of Dr. Rubin, a well recognized clinical leader in this field, strengthens the already excellent team in place and will open new avenues to improve the care we offer our patients even further.”

A nationally known expert in the management of ovarian cancer, Dr. Rubin's special interests include minimally invasive gynecologic surgery, hereditary ovarian cancer, and ovarian cancer clinical trials. Previously, he served as Chief of Gynecologic Oncology at the University of Pennsylvania School of Medicine and Health System and Director of the Gynecologic Oncology Research Program of Penn’s Abramson Cancer Center. Dr. Rubin also served as the Franklin Payne Chair in Gynecologic Oncology at the University of Pennsylvania School of Medicine, where he was a Professor of obstetrics and gynecology with tenure.

“I am absolutely delighted to be practicing at Fox Chase, the region’s only hospital devoted exclusively to cancer treatment, prevention, and research,” says Dr. Rubin. “Here, I can offer my patients the latest in cutting-edge care for gynecologic cancers and related conditions.”

Dr. Rubin received his medical degree from the University of Pennsylvania School of Medicine. He completed a residency in obstetrics and gynecology as well as a gynecologic oncology fellowship at the Hospital of the University of Pennsylvania.

Among his professional activities, Dr. Rubin is a member of numerous professional and scientific societies, including: the American College of Obstetricians and Gynecologists, American Gynecological and Obstetrical Society, Society of Gynecologic Oncologists, Society for Gynecologic Investigation, American College of Surgeons, American Society of Clinical Oncology, Society of Pelvic Surgeons, Philadelphia College of Physicians, Obstetrical Society of Philadelphia, and Mid-Atlantic Gynecologic Oncology Society.

Dr. Rubin has also served as an editor for some of the leading professional journals in his field, such as Gynecologic OncologyInternational Journal of Oncology, and Annals of Surgical Oncology.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

 

For more information, call 888-369-2427

Connect with Fox Chase